Mustang Bio, Inc.
NASDAQ Global MarketTotal Valuation
Mustang Bio, Inc. carries a market capitalization of 5.62M, placing it among publicly traded companies globally. Its enterprise value stands at -12.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.62M |
| Enterprise Value | -12.13M |
Share Statistics
Mustang Bio, Inc. currently has 7.58M shares outstanding.
| Shares Outstanding | 7.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.01 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | -0.84 |
| P/OCF Ratio | -0.84 |
Financial Position
Mustang Bio, Inc. maintains a current ratio of 2.12, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.12 |
| Quick Ratio | 2.10 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -17.29 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Mustang Bio, Inc.'s stock has declined approximately -42.52713% over the past 52 weeks. The 50-day moving average sits at 0.72, while the 200-day moving average is 1.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -42.52713% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.11 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -3.24M, while operating income came in at -3.24M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -3.24M |
| Pretax Income | -2.72M |
| Net Income | -2.72M |
| EBITDA | -3.24M |
| EBIT | -3.24M |
| Earnings Per Share (EPS) | -0.48 |
Balance Sheet
Total book value stands at -399.60M, with working capital of 8.75M providing operational flexibility.
| Cash & Cash Equivalents | 16.26M |
| Total Debt | N/A |
| Net Debt | -16.26M |
| Equity (Book Value) | -399.60M |
| Book Value Per Share | -70.55 |
| Working Capital | 8.75M |
Cash Flow
Mustang Bio, Inc. produced -4.88M in operating cash flow over the past twelve months.
| Operating Cash Flow | -4.88M |
| Capital Expenditures | N/A |
| Free Cash Flow | -4.88M |
| FCF Per Share | -0.86 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -167.57 |
| FCF Yield | -118.42 |
Stock Splits
Mustang Bio, Inc.'s most recent stock split took place on January 16, 2025 with a 50:1 split ratio.
| Last Split Date | 1/16/2025 |
| Split Ratio | 50:1 |
Scores
Mustang Bio, Inc. posts an Altman Z-Score of -33.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -33.44 |